Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical use of dopamine transporter imaging in movement disorders: benefits of appropriate use.

Literature DB >> 18425514

Clinical use of dopamine transporter imaging in movement disorders: benefits of appropriate use.

Giovanni Lucignani¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2008 PMID： 18425514 DOI： 10.1007/s00259-008-0792-3

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. Impact of instrumentation on DaTSCAN imaging: how feasible is the concept of cross-systems correction factor?

Authors: J J Zaknun; H Schücktanz; F Aichner
Journal: Q J Nucl Med Mol Imaging Date: 2007-06 Impact factor: 2.346

2. Role of DAT-SPECT in diagnostic work-up of Parkinsonism.

Authors: Wim E J Weber; Annemarie M M Vlaar
Journal: Mov Disord Date: 2008-04-15 Impact factor: 10.338

3. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.

Authors: Andrea Varrone; Valeria Sansone; Maria Teresa Pellecchia; Marianna Amboni; Elena Salvatore; Giuseppe De Michele; Alessandro Filla; Paolo Barone; Sabina Pappatà; Marco Salvatore
Journal: Eur J Nucl Med Mol Imaging Date: 2008-02-19 Impact factor: 9.236

Review 4. Role of DAT-SPECT in the diagnostic work up of parkinsonism.

Authors: Christoph Scherfler; Johannes Schwarz; Angelo Antonini; Donald Grosset; Francesc Valldeoriola; Kenneth Marek; Wolfgang Oertel; Eduardo Tolosa; Andrew J Lees; Werner Poewe
Journal: Mov Disord Date: 2007-07-15 Impact factor: 10.338

5. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study.

Authors: Po See Chen; Yen Kuang Yang; Tzung Lieh Yeh; I-Hui Lee; Wei Jen Yao; Nan Tsing Chiu; Ru Band Lu
Journal: Neuroimage Date: 2007-11-21 Impact factor: 6.556

6. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.

Authors: Eduardo Tolosa; Thierry Vander Borght; Emilio Moreno
Journal: Mov Disord Date: 2007-12 Impact factor: 10.338

Clinical use of dopamine transporter imaging in movement disorders: benefits of appropriate use.

1. Impact of instrumentation on DaTSCAN imaging: how feasible is the concept of cross-systems correction factor?

2. Role of DAT-SPECT in diagnostic work-up of Parkinsonism.

3. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.

Review 4. Role of DAT-SPECT in the diagnostic work up of parkinsonism.

5. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study.

6. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.

Review 7. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs.

8. Dopamine transporter binding in smokers and nonsmokers.

9. Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes.

10. Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes.